Approval · Notice of Compliance 38302 · 2026
MYPREF: Notice of Compliance 38302
Issued September 18, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38302
- Date
- September 18, 2026
- Company
- Ambicare Pharmaceuticals Inc.Oakville, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- PLAN B (Foundation Consumer Healthcare, Llc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYPREF | 02571587 | Approved |
Medicinal ingredients
- LEVONORGESTREL 1.5 MG per TAB